在培养细胞中,STAU1表现出双重功能,通过促进氨基化和 fosforylation 在培养细胞中
Chen-Lu Li1, Gui-Feng Zhou1, Xiao-Yong Xie1
1Department of Neurology, The First Affiliated Hospital Of Chongqing Medical University, Chongqing Key Laboratory of Major Neurological and Mental Disorders, Chongqing Key Laboratory of Neurology, 1 Youyi Road, Chongqing 400016, China.
Experimental neurology
|May 10, 2024
概括
在阿尔茨海默病 (AD) 模型中,Staufen-1 (STAU1) 蛋白质水平增加. 通过影响BACE1 mRNA和GADD45B表达,STAU1促进了粉样β和Tau病理,这表明STAU1是AD的治疗标.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 的特点是粉样β (Aβ) 斑块和tau神经纤维状结.
- Staufen-1 (STAU1) 是一种双链RNA结合蛋白,与各种病理有关.
研究的目的:
- 调查STAU1在阿尔茨海默氏症病原发生中的作用.
- 阐明STAU1影响Aβ和Tau病理的分子机制.
主要方法:
- 在AD的细胞和动物模型中分析STAU1蛋白水平.
- 在STAU1的淘汰和过度表达研究中.
- mRNA稳定性测试和转录组分析.
- 西方斑点测试用于评估蛋白质含量和酸化.
主要成果:
- 在AD模型中,STAU1蛋白水平升高.
- 通过增加BACE1的mRNA衰变,STAU1 knockdown降低了BACE1和Aβ水平.
- STAU1增强了GADD45B的表达,从而通过P38 MAPK信号传递在特定部位 (Ser396和Thr181) 增加了Tau酸化.
结论:
- 通过稳定BACE1mRNA,STAU1促进氨基二代,并通过激活GADD45B/P38 MAPK信号来促进陶病.
- 向STAU1为阿尔茨海默病提供了潜在的治疗策略,通过解决粉样蛋白和蛋白病理.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Phosphorylation
50.3K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.3K
Microtubule Associated Proteins (MAPs)
4.3K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.3K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K


